IIM
ABUS icon

INTECH Investment Management’s Arbutus Biopharma ABUS Stock Holding History

INTECH Investment Management’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$151K Sell
33,574
-36,989
-52% -$162K ﹤0.01% 1818
2025
Q4 		$339K Buy
70,563
+23,074
+49% +$104K ﹤0.01% 1696
2025
Q3 		$216K Sell
47,489
-28,360
-37% -$104K ﹤0.01% 2022
2025
Q2 		$234K Hold
75,849
– – ﹤0.01% 2006
2025
Q1 		$265K Buy
75,849
+18,765
+33% +$62.6K ﹤0.01% 1957
2024
Q4 		$187K Buy
57,084
+20,232
+55% +$74.4K ﹤0.01% 2056
2024
Q3 		$142K Buy
+36,852
New +$141K ﹤0.01% 1821

Other funds holding ABUS

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
WCM
Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

INTECH Investment Management's ABUS Position: Q1 2026 in Review

INTECH Investment Management reduced its Arbutus Biopharma (ABUS) stake by 52% in Q1 2026, selling an estimated $162K and leaving 33,574 shares worth $151K. The position accounts for ﹤0.01% of the portfolio, ranked #1818.

INTECH Investment Management first reported a position in ABUS in Q3 2024 and has held it in 7 quarters since. The position peaked at $339K in Q4 2025. 167 funds tracked by Wall St. Rank hold ABUS as of Q1 2026.

  • INTECH Investment Management held 33,574 shares of Arbutus Biopharma worth $151K as of Q1 2026.
  • INTECH Investment Management sold 36,989 Arbutus Biopharma shares in Q1 2026, an estimated $162K.
  • Arbutus Biopharma made up ﹤0.01% of INTECH Investment Management's portfolio in Q1 2026, its #1818 holding.
  • INTECH Investment Management first reported a position in Arbutus Biopharma in Q3 2024 and has held it in 7 quarters since.
  • INTECH Investment Management's Arbutus Biopharma position peaked at $339K in Q4 2025.
  • 167 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.